Skip to main content
Therma Bright Inc. logo

Therma Bright Inc. — Investor Relations & Filings

Ticker · THRM ISIN · CA8834262070 LEI · 529900PN7P0GSORO2174 TSXV Manufacturing
Open in API
Filings indexed 525 across all filing types
Latest filing 2020-07-22 Capital/Financing Update
Country CA Canada
Listing TSXV THRM

About Therma Bright Inc.

https://www.thermabright.com/

Therma Bright Inc. is a medical technology company that develops, acquires, and markets proprietary diagnostic and medical device technologies for the consumer and institutional healthcare sectors. The company's portfolio addresses key areas including pain management, circulation, diagnostics, and critical care. Core products and development projects include Venowave, a medical device designed to boost circulation and prevent blood clots; the Digital Cough Test (DCT), an AI-powered application developed with AI4LYF for rapid, non-invasive detection of respiratory diseases; and the PREVA™ clot retriever, developed with Inretio for enhanced thrombectomy procedures in ischemic stroke treatment. Furthermore, Therma Bright is advancing inhaled statin therapy in partnership with InVixa for the treatment of COVID-19 pneumonia and Acute Respiratory Distress Syndrome (ARDS).

Recent filings

Filing Released Lang Actions
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a news release announcing an increase in a private placement financing amount from $1,000,000 to $1,250,000, along with details about the issuance of units and warrants, and additional debt settlements involving share issuance. It focuses on fundraising activities and capital structure changes. There is no indication that this is a full financial report, audit, or earnings release. The content aligns with updates on company fundraising and capital structure changes, which fits the Capital/Financing Update category. The document length is about 4981 characters, which is sufficient for a detailed announcement rather than a brief notice. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2020-07-22 English
Material change report - English.pdf
Regulatory Filings
2020-07-20 English
News release - English.pdf
Regulatory Filings
2020-07-20 English
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is a FORM 51-102F3 Material Change Report filed by Therma Bright Inc. It provides an update on a material change regarding the development of a COVID-19 rapid test. The document includes details about the change, the date, and contact information, and references a news release. It is a regulatory filing reporting a material change event, not a full financial report, earnings release, or other specific report type. The document is about a material change disclosure under Canadian securities regulations, which fits the category of Regulatory Filings (RNS) as it does not fit other more specific categories like Annual Report, Earnings Release, or Capital Update. The length and content confirm it is a standalone material change report rather than an announcement of a report publication or a proxy statement.
2020-07-16 English
News release - English.pdf
Regulatory Filings
2020-07-16 English
Material change report - English.pdf
Regulatory Filings
2020-07-09 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.